Sramana Mitra: What is the go-to market strategy of the diagnostic product? Ritesh Agarwal: They’re mostly in B2C. They’re selling the kit on Amazon or through their website. They want to go into more wellness sites – into B2B. That’s their next step.
Sramana Mitra: Switching gears a bit, tell us a bit of a few companies you’ve invested in. Maybe start with the two that are turning into unicorns. Tell us where you encountered them and how you encountered them. What state were they in? What did you see in those companies that told you that this
Sramana Mitra: I’m going to ask you for a couple of more specific points on that. You have a CIO panel. Do you also have a CISO panel that you check with when you do cyber security investments? Ritesh Agarwal: Primarily CIO. If the CIO feels that he needs to get his extended team involved,
Responding to a popular request, we are now sharing transcripts of our investor podcast interviews in this new series. The following interview with Ritesh Agarwal was recorded in April 2020. Ritesh Agarwal is Co-Founder and Managing Director at CerraCap Ventures, a deep tech-focused early stage firm.
Ritesh Agarwal is Co-founder and Managing Director at CerraCap Ventures, a deep tech focused early stage firm.